1. Home
  2. ALLT vs SLDB Comparison

ALLT vs SLDB Comparison

Compare ALLT & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allot Ltd.

ALLT

Allot Ltd.

HOLD

Current Price

$7.03

Market Cap

325.8M

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$8.22

Market Cap

498.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLT
SLDB
Founded
1996
2013
Country
Israel
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
325.8M
498.6M
IPO Year
2006
2017

Fundamental Metrics

Financial Performance
Metric
ALLT
SLDB
Price
$7.03
$8.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
11
Target Price
$12.40
$16.36
AVG Volume (30 Days)
317.7K
1.1M
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.97
EPS
N/A
N/A
Revenue
N/A
$8,094,000.00
Revenue This Year
$15.84
N/A
Revenue Next Year
$12.08
N/A
P/E Ratio
$469.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.25
$2.45
52 Week High
$11.92
$8.69

Technical Indicators

Market Signals
Indicator
ALLT
SLDB
Relative Strength Index (RSI) 50.31 61.59
Support Level $6.16 $5.16
Resistance Level $8.20 $8.47
Average True Range (ATR) 0.29 0.63
MACD 0.12 0.08
Stochastic Oscillator 77.50 77.04

Price Performance

Historical Comparison
ALLT
SLDB

About ALLT Allot Ltd.

Allot Ltd is a provider of security and network intelligence solutions for mobile, fixed, and cloud service providers, as well as enterprises. It offers network-based security solutions such as mobile security, DDoS protection, and IoT security, along with network analytics and traffic management. It focuses on expanding its Security-as-a-Service (SECaaS) offerings through the Allot Secure product family, which delivers unified protection for consumers and SMBs across mobile, fixed, and 5G networks. Its Allot Smart solutions enable service providers to analyze and manage network data, optimize performance, reduce costs, and enhance user experience. It has a customer base in Europe, which generates maximum revenue, as well as in Asia and Oceania, the Americas, the Middle East, and Africa.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: